---
title: "Where Polygenic and Proteomic Risk Scores Diverge in Neurodegenerative Disease: Absorption and Co-"
id: "medrxiv-10-absorption-and-co-expression-modules-show-where-polygenic-and-proteomic-risk"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-10-absorption-and-co-expression-modules-show-where-polygenic-and-proteomic-risk"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.24.26361271v1?rss=1"
published_at: "2026-08-27T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Where Polygenic and Proteomic Risk Scores Diverge in Neurodegenerative Disease: Absorption and Co-
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-10-absorption-and-co-expression-modules-show-where-polygenic-and-proteomic-risk
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.24.26361271v1?rss=1)
- **Published At:** 2026-08-27T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study quantifies overlap between **polygenic risk scores (PRS)** and **proteomic risk scores (ProRS)** in neurodegenerative diseases by defining "absorption" as the fraction of a PRS's predictive contribution explained by an out-of-fold ProRS. - Absorption was estimated in UK Biobank samples (n = 9,434 to 9,820 participants) and co-expression modules were built using plasma proteomes from 41,358 disease-free participants. - Matched SNP heritability (h2) did not predict absorption: Alzheimer’s disease with APOE, Alzheimer’s without APOE, and Parkinson’s had SNP h2 of 0.068, 0.061 and 0.069 but absorption values of 0.73, 0.39 and 0.19, respectively; amyotrophic lateral sclerosis (ALS) showed absorption of 0.22. - A residual genetic signal remained for all four diseases, indicating **proteomic risk scores did not fully capture PRS predictive information**. - Proteins associated with a PRS and proteins selected by a ProRS overlapped no more than expected by chance, except in settings dominated by **APOE**. - Across 33 plasma **co-expression modules**, germline signal concentrated in specific modules rather than being diffusely distributed. Seven module summary components associated with the Alzheimer’s score including APOE; none associated with the Parkinson’s score. - The lysosomal module M32 encodes lysosomal genetic architecture relevant to Parkinson’s, contains 89% of members associated with Alzheimer’s germline risk, yet none of its proteins were used by the proteomic score. - Rebuilding modules in the All of Us cohort yielded an adjusted Rand index of 0.582 versus 0.686 attainable within that cohort; 29 of 33 modules remained coherent above a permutation null, supporting cross-cohort reuse of the module partition as a reference dictionary. - Data sources: UK Biobank and All of Us Research Program; code and resources are available in the authors’ GitHub repository. - Ethical approvals and participant consent were reported; authors declared no competing interests.
## Clinical Analysis & Structured Key Points
Absorption and Co-expression Modules Show Where Polygenic and Proteomic Risk Scores Diverge in Neurodegenerative Diseases | medRxiv Skip to main content Absorption and Co-expression Modules Show Where Polygenic and Proteomic Risk Scores Diverge in Neurodegenerative Diseases Charles Zheng , Manu Shivakumar , View ORCID Profile Li Shen , Dokyoon Kim doi: https://doi.org/10.64898/2026.08.24.26361271 Charles Zheng University of Pennsylvania Find this author on Google Scholar Find this author on PubMed Search for this author on this site Manu Shivakumar University of Pennsylvania Find this author on Google Scholar Find this author on PubMed Search for this author on this site Li Shen University of Pennsylvania Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Li Shen Dokyoon Kim University of Pennsylvania Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: dokyoon.kim{at}pennmedicine.upenn.edu Abstract Info/History Metrics Data/Code Preview PDF Abstract Polygenic and proteomic risk scores are both proposed for pre-symptomatic stratification, yet the extent to which they provide overlapping or complementary information has not been measured across neurodegenerative disease. To quantify this overlap, we define absorption as the fraction of a polygenic score's predictive contribution accounted for by an out-of-fold proteomic score and estimate it among 9,434 to 9,820 UK Biobank participants. Absorption did not track h2, as Alzheimer's with APOE, Alzheimer's without APOE and Parkinson's carried matched SNP h2 of 0.068, 0.061 and 0.069 yet absorbed 0.73, 0.39 and 0.19, with amyotrophic lateral sclerosis at 0.22. Residual genetic signal remained in all four, indicating that proteomic risk scores did not fully capture the predictive information contained in polygenic risk scores. The proteins associated with a polygenic score and the proteins a proteomic score selects overlap no more often than chance, converging only where APOE dominates. Across 33 plasma co-expression modules built in 41,358 disease-free participants, germline signal concentrates in modules rather than spreading, with the summary component of seven modules associated with the score for Alzheimer's with APOE and none for Parkinson's, even though Parkinson's carries the lysosomal genetic architecture that the lysosomal module M32 encodes. This module has 89% of its members associated with AD germline risk yet none was used by the proteomic score. Rebuilding the co-expression modules in All of Us gave an adjusted Rand index of 0.582 against the 0.686 attainable within that cohort, and 29 of 33 modules stayed together above a permutation null. Cross-cohort transferability was predictable from module coherence in the discovery cohort, supporting the reuse of this module partition as a fixed reference dictionary. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study analyzed de-identified secondary data from the UK Biobank and the All of Us Research Program. UK Biobank is approved by the North West Multi-centre Research Ethics Committee (MREC; ref 11/NW/0382), and All of Us is approved by the All of Us IRB; all participants provided informed consent. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The data supporting these findings are available through the UK Biobank (ukbiobank.ac.uk) and the All of Us Research Program (researchallofus.org) to authorized researchers upon approval of an access application. https://github.com/czbw022/Absorption-and-Co-expression-Modules-Show-Where-PRS-ProRS-Diverge-in-Neurodegenerative-Diseases Funder Information Declared National Institute of Health , U01 AG068057 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Posted August 27, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Absorption and Co-expression Modules Show Where Polygenic and Proteomic Risk Scores Diverge in Neurodegenerative Diseases Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Absorption and Co-expression Modules Show Where Polygenic and Proteomic Risk Scores Diverge in Neurodegenerative Diseases Charles Zheng , Manu Shivakumar , Li Shen , Dokyoon Kim medRxiv 2026.08.24.26361271; doi: https://doi.org/10.64898/2026.08.24.26361271 Share This Article: Copy Citation Tools Absorption and Co-expression Modules Show Where Polygenic and Proteomic Risk Scores Diverge in Neurodegenerative Diseases Charles Zheng , Manu Shivakumar , Li Shen , Dokyoon Kim medRxiv 2026.08.24.26361271; doi: https://doi.org/10.64898/2026.08.24.26361271 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (612) Allergy and Immunology (892) Anesthesia (325) Cardiovascular Medicine (4753) Dentistry and Oral Medicine (474) Dermatology (406) Emergency Medicine (640) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1610) Epidemiology (15800) Forensic Medicine (32) Gastroenterology (1194) Genetic and Genomic Medicine (6967) Geriatric Medicine (726) Health Economics (1050) Health Informatics (4958) Health Policy (1422) Health Systems and Quality Improvement (1731) Hematology (578) HIV/AIDS (1329) Infectious Diseases (except HIV/AIDS) (16227) Intensive Care and Critical Care Medicine (1158) Medical Education (661) Medical Ethics (150) Nephrology (718) Neurology (7161) Nursing (360) Nutrition (1072) Obstetrics and Gynecology (1226) Occupational and Environmental Health (998) Oncology (3563) Ophthalmology (1032) Orthopedics (392) Otolaryngology (445) Pain Medicine (464) Palliative Medicine (139) Pathology (702) Pediatrics (1770) Pharmacology and Therapeutics (730) Primary Care Research (758) Psychiatry and Clinical Psychology (5812) Public and Global Health (9664) Radiology and Imaging (2371) Rehabilitation Medicine and Physical Therapy (1427) Respiratory Medicine (1236) Rheumatology (631) Sexual and Reproductive Health (762) Sports Medicine (572) Surgery (762) Toxicology (106) Transplantation (301) Urology (285)
## Related Clinical Research

- [Polytranscriptomic scores reveal novel cross-trait links and improve Parkinson's disease prediction](https://medichelpline.com/clinical-feed/medrxiv-17-cross-trait-and-multi-polytranscriptomic-score-analysis-of-parkinson-s-disease.md)
- [High-dose vitamin D (≥5,000 IU) linked to better cognition in older adults with MCI and sleep prob](https://medichelpline.com/clinical-feed/medical-news-today-1-high-dose-vitamin-d-may-boost-brain-heath-in-older-adults-at-risk-of-dementia.md)
- [Pre-diagnostic 1-year prevalence of polypharmacy and PIMcog in Norwegian outpatients with MCI or d](https://medichelpline.com/clinical-feed/plos-one-14-one-year-pre-diagnostic-prevalence-and-associated-factors-of-polypharmacy-and.md)
- [Leisure physical activity lowers dementia risk while occupational activity may raise it, review fi](https://medichelpline.com/clinical-feed/medical-news-today-0-physical-activity-protects-brain-health-but-only-if-you-enjoy-it-study-says.md)
- [Bupropion Hydrochloride for Improving Recovery in Acute Ischaemic Stroke: BASE Trial Protocol](https://medichelpline.com/clinical-feed/bmj-open-4-protocol-for-base-a-multicentre-double-blind-randomised-controlled-trial-of.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.